ginkgolide b has been researched along with puromycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braquet, P; Bricio, T; Cobo, ME; Egido, J; González, E; Hernando, L; Mampaso, FM; Martínez-Montero, JC; Pirotzky, E | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for ginkgolide b and puromycin
Article | Year |
---|---|
Interstitial mononuclear cell infiltrates in experimental nephrosis: effect of PAF antagonist.
Topics: Acetates; Animals; Antibodies, Monoclonal; Disease Models, Animal; Diterpenes; Doxorubicin; Ginkgolides; Immunoenzyme Techniques; In Vitro Techniques; Kidney; Kidney Glomerulus; Lactones; Male; Nephritis, Interstitial; Nephrotic Syndrome; Platelet Activating Factor; Proteinuria; Puromycin; Rats; Rats, Inbred Strains | 1989 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |